There are a myriad of transcutaneous drug delivery techniques and systems already out there including a nifty silicon device with micro "needles". Unless this device has a compelling advantage, it seems a better vehicle for fleecing investors.
This interesting article raises several questions.
1/ The photograph makes the patch appear to be about 7 inches long. Is it really that big?
2/ The article mentions that consumers would expect to pay less than $10 and that reimbursement agencies expect to pay between $35 and $83. Should the article have said that reimbursement agencies see this technology replacing injections which currently cost $35 and $83?
3/ Migraines have historically been difficult to treat with drugs. How effective is this system compared with current treatments? Is this patch simply a superior delivery system for the same drug as current patch technologies?
NASA's Orion Flight Software Production Systems Manager Darrel G. Raines joins Planet Analog Editor Steve Taranovich and Embedded.com Editor Max Maxfield to talk about embedded flight software used in Orion Spacecraft, part of NASA's Mars mission. Live radio show and live chat. Get your questions ready.
Brought to you by